IL-15 exacerbates collagen-induced arthritis with an enhanced CD4+ T cell response to produce IL-17

European Journal of Immunology

Volumn 37, Issue 10, 2007, Pages 2744-2752

  Yoshihara, Kazufumi ^a,b   Yamada, Hisakata ^a   Hori, Akiko ^a   Yajima, Toshiki ^a   Kubo, Chiharu ^b   Yoshikai, Yasunobu ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Autoimmunity; CD4 T cells; Cytokines

Indexed keywords

COLLAGEN TYPE 2; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 23;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DOWN REGULATION; IMMUNOPATHOGENESIS; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RHEUMATOID ARTHRITIS; UPREGULATION; WILD TYPE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; COLLAGEN TYPE II; EPITOPES, T-LYMPHOCYTE; INTERLEUKIN-15; INTERLEUKIN-17; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC;

EID: 35348889009     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200737229     Document Type: Article

References (50)

1. Moreland, L. W., Baumgartner, S. W., Schiff, M. H., Tindall, A., Fleischmann, R. M., Weaver, A. L., Ettlinger, E. et al., Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N. Engl. J. Med. 1997. 337: 141-147.
2. Bresnihan, B., Alvaro-Gracia, J. M., Cobby, M., Doherty, M., Domljan, Z., Emery, P., Nuld, G. et al., Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum. 1998. 41: 2196-2204.
3. Holmdahl, R., Bockermann, R., Backlund, J. and Yamada, H., The molecular pathogenesis of collagen-induced arthritis in mice - a model for rheumatoid arthritis. Ageing Res. Rev. 2002. 1: 135-147.
4. Williams, R. O., Mason, L. J., Feldmann, M. and Maini, R. N., Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis. Proc. Natl. Acad. Sci. USA 1994. 91: 2762-2766.
5. Bakker, A. C., Joosten, L. A., Arntz, O. J., Helsen, M. M., Bendele, A. M., van de Loo, F. A. and van den Berg, W. B., Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee. Arthritis Rheum. 1997. 40: 893-900.
6. Seki, N., Sudo, Y., Yoshioka, T., Sugihara, S., Fujitsu, T., Sakuma, S., Ogawa, T. et al., Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J. Immunol. 1988. 140: 1477-1484.
7. Lubberts, E., Koenders, M. I., Oppers-Walgreen, B., van den Bersselaar, L., Coenen-de Roo, C. J., Joosten, L. A. and van den Berg, W. B., Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum. 2004. 50: 650-659.
8. Nakae, S., Nambu, A., Sudo, K. and Iwakura, Y., Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 2003. 171: 6173-6177.
9. Rouvier, E., Luciani, M. F., Mattei, M. G., Denizot, F. and Golstein, P., CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J. Immunol. 1993. 150: 5445-5456.
10. Infante-Duarte, C., Horton, H. F., Byrne, M. C. and Kamradt, T., Microbial lipopeptides induce the production of IL-17 in Th cells. J. Immunol. 2000. 165: 6107-6115.
11. Jovanovic, D. V., Di Battista, J. A., Martel-Pelletier, J., Jolicoeur, F. C., He, Y., Zhang, M., Mineau, F. et al., IL-17 stimulates the production and expression of proinflammatory cytokines, IL-1β and TNF-α, by human macrophages. J. Immunol. 1998. 160: 3513-3521.
12. Oppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F. et al., Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000. 13: 715-725.
13. Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T. et al., IL-23 drives a pathogenic T cell population that induces autoinumme inflammation. J. Exp. Med. 2005. 201: 233-240.
14. Murphy, C. A., Langrish, C. L., Chen, Y., Blumenschein, W., McClanahan, T., Kastelein, R. A., Sedgwick, J. D. et al., Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 2003. 198: 1951-1957.
15. Grabstein, K. H., Eisenman, J., Shanebeck, K., Rauch, C., Srinivasan, S., Fung, V., Beers, C. et al., Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 1994. 264: 965-968.
16. Giri, J. G., Ahdieh, M., Eisenman, J., Shanebeck, K., Grabstein, K., Kumaki, S., Namen, A. et al., Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 1994. 13: 2822-2830.
17. Tagaya, Y., Bamford, R. N., DeFilippis, A. P. and Waldmann, T. A., IL-15: A pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 1996. 4: 329-336.
18. Bamford, R. N., Grant, A. J., Burton, J. D., Peters, C., Kurys, G., Goldman, C. K., Brennan, J. et al., The interleukin (IL-2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl. Acad. Sci. USA 1994. 91: 4940-4944.
19. Carson, W. E., Giri, J. G., Lindemann, M. J., Linett, M. L., Ahdieh, M., Paxton, R., Anderson, D. et al. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 1994. 180: 1395-1403.
20. Armitage, R. J., Maeduff B. M., Eisenman, J., Paxton, R. and Grabstein, K. H., IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J. Immunol. 1995. 154: 483-490.
21. Kennedy, M. K., Glaccum, M., Brown, S. N., Butz, E. A., Viney, J. L., Embers, M., Matsuki, N. et al., Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 2000. 191: 771-780.
22. Oppenheimer-Marks, N., Brezinschek, R. I., Mohamadzadeh, M., Vita, R. and Lipsky, P. E., Interleukin-15 is produced by endothelial cells and increases the transendothelial migration of T-cells in vitro and in the SCID mouse-human rheumatoid arthritis model in vivo. J. Clin. Invest. 1998. 101: 1261-1272.
23. Harada, S., Yamamura, M., Okamoto, H., Morita, Y., Kawashima, M., Aita, T. and Makino, H., Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum. 1999. 42: 1508-1516.
24. Kurowska, M., Rudnicka, W., Kontny, E, Janicka, L, Chorazy, M., Kowalczewski, J., Ziolkowska, M. et al., Fibroblast-like synoviocytes from rheumatoid arthritis patients express functional IL-15 receptor complex: Endogenous IL-15 in autocrine fashion enhances cell proliferation and expression of Bcl-xL and Bcl-2. J. Immunol. 2002. 169: 1760-1767.
25. McInnes, I. B., Al-Mughales, J., Field, M., Leung, B. P., Huang, F.-P., Dixon, R., Sturrock, R. D. et al., The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat. Med. 1996. 2 175-182.
26. Thurkow, E. W., Van Der Heijden, I. M., Breedveld, F. C., Smeets, T. J. M., Daha, M. R., Kluin, P. M., Meinders, A. E. et al., Increased expression of IL-15 in the synovium of patients with rheumatoid arthritis compared with patients with Yersinia-induced arthritis and osteoarthritis. J. Pathol. 1997. 181: 444-450.
27. McInnes, I. B., Leung, B. P., Sturrock, R. D., Field, M. and Liew, F. Y., Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis. Nat. Med. 1997. 3: 189-195.
28. Baslund, B., Tvede, N., Danneskiold-Samsoe, B., Larsson, P., Panayi, G., Petersen, J., Gracie, J. A. et al., Targeting interleukin-15 in patients with rheumatoid arthritis: A proof-of-concept study. Arthritis Rheum. 2005. 52: 2686-2692.
29. Ruchatz, H., Leung, B. P., Wei, X.-Q., McInnes, I. B. and Liew, F. Y., Soluble IL-15 receptor α-chain administration prevents murine collagen-induced arthritis: A role for IL-15 in development of antigen-induced immunopathology. J. Immunol. 1998. 160: 5654-5660.
30. Ferrari-Lacraz, S., Zanelli, E., Neuberg, M., Donskoy, E., Kim, Y. S., Zheng, X. X., Hancock, W. W. et al., Targeting IL-15 receptor-bearing cells with an antagonist mutant IL-15/Fc protein prevents disease development and progression in murine collagen-induced arthritis. J. Immunol. 2004. 173: 5818-5826.
31. Ziolkowska, M., Koc, A., Luszczykiewicz, G., Ksiezopolska-Pietrzak, K., Klimczak, E., Chwalinska-Sadowska, H. and Maslinski, W., High levels of IL-17in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporine A sensitive mechanism. J. Immunol. 2000. 164: 2832-2838.
32. Ferretti, S., Bonneau, O., Dubois, G. R., Jones, C. E. and Trifilieff, A., IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J. Immunol. 2003. 170: 2106-2112.
33. Campbell, I. K., Hamilton, J. A. and Wicks, I. P., Collagen-induced arthritis in C57BL/6 (H-2b) mice: New insights into an important disease model of rheumatoid arthritis. Eur. J. Immunol. 2000. 30: 1568-1575.
34. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L. et al., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006. 11: 235-238.
35. Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D. et al., Transforming growth factor-beta induces development of the T(H) 17 lineage. Nature 2006. 11: 231-234.
36. Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., Stockinger, B., TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006. 24: 179-189.
37. Parham, C., Chirica, M., Timans, J., Vaisberg, E., Travis, M., Cheung, J., Pflanz, S. et al., A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 2002. 168: 5699-5708.
38. Presky, D. H., Yang, H., Minetti, L. J., Chua, A. O., Nabavi, N., Wu, C. Y., Gately, M. K. et al., A functional interleukin 12 receptor complex is composed of two betatype cytokine receptor subunits. Proc. Natl. Acad. Sci. USA 1996. 93: 14002-14007.
39. Mullen, A. C., High, F. A., Hutchins, A. S., Lee, H. W., Villarino, A. V., Livingston, D. M, Kung, A. L. et al., Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 2001. 292: 1907-1910.
40. + T cells. Nat. Immunol. 2002. 3: 549-557.
41. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005. 6: 1123-1132.
42. Musikacharoen, T., Oguma, A., Yoshikai, Y., Chiba, N., Masuda, A. and Matsuguchi, T., Interleukin-15 induces IL-12 receptor beta1 gene expression through PU.1 and IRF 3 by targeting chromatin remodeling. Blood 2005. 105: 711-720.
43. Sutton, C., Brereton, C., Keogh, B., Mills, K. H. and Lavelle, E. C., A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 2006. 203: 1685-1691.
44. Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K. et al., IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2006. 177: 566-573.
45. Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., McKenzie, B., Kleinschek, M. A. et al., IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 2006. 116: 1310-1316.
46. Kotake, S., Udagawa, N., Takahashi, N., Matsuzaki, K., Itoh, K., Ishiyama, S., Saito, S. et al., IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. 1999. 103: 1345-1352.
47. + T cell contraction during primary infection. J. Immunol. 2006. 176: 507-515.
48. Nishimura, H., Yajima, T., Naiki, Y., Tsunobuchi, H., Umemura, M., Itano, K., Matsuguchi, T. et al., Differential roles of interleukin 15 mRNA isoforms generated by alternative splicing in immune responses in vivo. J. Exp. Med. 2000. 191: 157-170.
49. Williams, R. O., Feldmann, M. and Maini, R. N., Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. USA 1992. 89: 9784-9788.
50. Li, J., Gran, B., Zhang, G. X., Ventura, E. S., Siglienti, I., Rostami, A. and Kamoun, M., Differential expression and regulation of IL-23 and IL-12 subunits and receptors in adult mouse microglia. J. Neurol. Sci. 2003. 215: 95-103.